Literature DB >> 16524739

Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers' pneumoconiosis.

Rachel Nadif1, Margaret Mintz, Selma Rivas-Fuentes, Anne Jedlicka, Elise Lavergne, Mathieu Rodero, Francine Kauffmann, Christophe Combadière, Steven R Kleeberger.   

Abstract

Chemokines and their receptors are key regulators of inflammation and may participate in the lung fibrotic process. Associations of polymorphisms in CCL5 (G-403A) and its receptor CCR5 (Delta32), CCL2 (A-2578G) and CCR2 (V64I), and CX3CR1 V249I and T280M with coal worker's pneumoconiosis (CWP) were investigated in 209 miners examined in 1990, 1994 and 1999. Coal dust exposure was assessed by job history and ambient measures. The main health outcome was lung computed tomography (CT) score in 1990. Internal coherence was assessed by studying CT score in 1994, 4-year change in CT score, and CWP prevalence in 1999. CCR5 Delta32 carriers had significantly higher CT score in 1990 and 1994 (2.15 vs. 1.28, p=0.01; 3.04 vs. 1.80, p=0.04). The CX3CR1 I249 allele was significantly associated with lower 1990 CT score and lower progression in 4-year change in CT score in CCR5 Delta32 carriers only (p for interaction=0.03 and 0.02). CX3CR1 V249I was associated with lower 1999 CWP prevalence (16.7%, 13.2%, 0.0% for VV, VI and II); the effect was most evident in miners with high dust exposure (31.6%, 21.7%, 0.0%). Our findings indicate that chemokine receptors CCR5 and CX3CR1 may be involved in the development of pneumoconiosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16524739      PMCID: PMC1913495          DOI: 10.1016/j.cyto.2006.01.001

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  47 in total

1.  Polymorphism in RANTES chemokine promoter affects extent of sarcoidosis in a Japanese population.

Authors:  T Takada; E Suzuki; T Ishida; H Moriyama; H Ooi; T Hasegawa; H Tsukuda; F Gejyo
Journal:  Tissue Antigens       Date:  2001-11

2.  Association of CCR5Delta32 with reduced risk of childhood but not adult asthma.

Authors:  P Srivastava; P J Helms; D Stewart; M Main; G Russell
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

Review 3.  Knock out models to dissect chemokine receptor function in vivo.

Authors:  Christine A Power
Journal:  J Immunol Methods       Date:  2003-02       Impact factor: 2.303

4.  A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma.

Authors:  Nobuyuki Hizawa; Etsuro Yamaguchi; Satoshi Konno; Yoko Tanino; Eisei Jinushi; Masaharu Nishimura
Journal:  Am J Respir Crit Care Med       Date:  2002-09-01       Impact factor: 21.405

5.  Further support for the association of CCR5 allelic variants with asthma susceptibility.

Authors:  R McGinnis; F Child; S Clayton; S Davies; W Lenney; T Illig; M Wjst; N Spurr; C Debouck; A H Hajeer; W E R Ollier; R Strange; A A Fryer
Journal:  Eur J Immunogenet       Date:  2002-12

6.  Two polymorphisms in the fracalkine receptor CX3CR1 are not associated with peripheral arterial disease.

Authors:  Alexander Gugl; Wilfried Renner; Gerald Seinost; Marianne Brodmann; Edmund Pabst; Thomas C Wascher; Bernhard Paulweber; Bernhard Iglseder; Ernst Pilger
Journal:  Atherosclerosis       Date:  2003-02       Impact factor: 5.162

7.  The RANTES promoter polymorphism: a genetic risk factor for near-fatal asthma in Chinese children.

Authors:  Tsung-Chieh Yao; Ming-Ling Kuo; Lai-Chu See; Li-Chen Chen; Dah-Chin Yan; Liang-Shiou Ou; Cheng-Kuang Shaw; Jing-Long Huang
Journal:  J Allergy Clin Immunol       Date:  2003-06       Impact factor: 10.793

8.  Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans.

Authors:  David H McDermott; Alan M Fong; Qiong Yang; Joan M Sechler; L Adrienne Cupples; Maya N Merrell; Peter W F Wilson; Ralph B D'Agostino; Christopher J O'Donnell; Dhavalkumar D Patel; Philip M Murphy
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

9.  Effect of TNF and LTA polymorphisms on biological markers of response to oxidative stimuli in coal miners: a model of gene-environment interaction. Tumour necrosis factor and lymphotoxin alpha.

Authors:  R Nadif; A Jedlicka; M Mintz; J-P Bertrand; S Kleeberger; F Kauffmann
Journal:  J Med Genet       Date:  2003-02       Impact factor: 6.318

Review 10.  Chemokine receptors: multifaceted therapeutic targets.

Authors:  Amanda E I Proudfoot
Journal:  Nat Rev Immunol       Date:  2002-02       Impact factor: 53.106

View more
  2 in total

1.  Evidence of positive selection at codon sites localized in extracellular domains of mammalian CC motif chemokine receptor proteins.

Authors:  Kelsey J Metzger; Michael A Thomas
Journal:  BMC Evol Biol       Date:  2010-05-10       Impact factor: 3.260

2.  Selective elevation of circulating CCL2/MCP1 levels in patients with longstanding post-vaccinal macrophagic myofasciitis and ASIA.

Authors:  Josette Cadusseau; Nilusha Ragunathan-Thangarajah; Mathieu Surenaud; Sophie Hue; Francois-Jérôme Authier; Romain K Gherardi
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.